Target intelligence / Profile preview

MT-ND2 pseudogene 12 (MTND2P12)

Target
MTND2P12
Molecular classification
Pseudogene, Other
01

Overview

MT-ND2 pseudogene 12 (MTND2P12) is a nuclear pseudogene corresponding to the coding mitochondrial gene MT-ND2. Pseudogenes are genetic sequences resembling protein-coding genes but do not encode functional proteins, due to mutations or truncations. While some pseudogenes are transcribed and may have regulatory effects, MTND2P12 itself does not produce the functional NADH dehydrogenase subunit involved in mitochondrial electron transport. Recent transcriptomic studies have detected differential expression of MTND2P12 in Alzheimer's disease brain tissue, though its biological significance and relationship to disease remain speculative and subject to further research[2][5][6].

Other names
MTND2P12Mitochondrially encoded NADH:ubiquinone oxidoreductase core subunit 2 pseudogene 12
02

Mechanism of action

None. There are no known mechanisms of drug action for this pseudogene.

03

Biological functions

There is no proven biological function for this pseudogene; pseudogenes typically do not encode functional proteins. However, altered pseudogene expression has occasionally been associated with gene regulation in specific contexts and some recent studies suggest certain pseudogenes may have regulatory or non-coding RNA functions[5].
04

Disease associations

Other (Tentatively: some studies exploring pseudogene expression patterns in neurodegenerative diseases like Alzheimer's disease; direct disease roles are not established[5])

Beyond the preview

Go deeper on MT-ND2 pseudogene 12 (MTND2P12).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on MT-ND2 pseudogene 12 (MTND2P12).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call